Ketoacidosis associated with protease inhibitor therapy.
Besson
C
C
Jubault
V
V
Viard
J P
JP
Pialoux
G
G
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000150:complications; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir